WebMar 3, 2024 · The trial involved healthy infants born at term or late preterm (35 weeks gestational age or greater) entering their first RSV season and met the primary endpoint, reducing the incidence of medically attended lower respiratory tract infections (LRTI), such as bronchiolitis or pneumonia, caused by RSV by 74.5% (95% CI 49.6 to 87.1; P<0.001) … WebThe Harmony Reserve lifestyle is a maintenance-free lifestyle where all the drudgery of maintaining property is handled for you, giving you more time to enjoy your favorite …
RSV: Vaccine trial hopes to cut baby hospital admissions
WebApr 10, 2024 · RSV Vaccine Candidate Shows Promising Trial Results in Infants and Seniors Late-stage trials showed that Pfizer’s vaccine candidate was more than 80 percent effective at preventing severe... WebNov 9, 2024 · launch of HARMONIE study: investigating whether a single antibody dose protects infants from RSV (Respiratory Syncytial Virus infection) Respiratory Syncytial … michael mcgoldrick forgiveness
launch of HARMONIE study: investigating whether a single …
WebApr 5, 2024 · In this phase 3, double-blind trial conducted in 18 countries, we randomly assigned, in a 1:1 ratio, pregnant women at 24 through 36 weeks’ gestation to receive a single intramuscular injection... WebAug 19, 2024 · The HARMONIE study will look at the leading cause of infant hospitalisation. The ground-breaking study is a collaboration between Sanofi and the (NIHR). RSV … WebHarmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics Harmony Outcomes will assess the CV safety of albiglutide in patients with T2DM and CV disease. michael mcglynn south lanarkshire council